Literature DB >> 7545855

National Hospital Discharge Survey: annual summary, 1993.

E J Graves1.   

Abstract

This report presents statistics on the utilization of non-Federal short-stay hospitals based on data collected through the National Hospital Discharge Survey from a national sample of the hospital records of discharged inpatients. Estimates are provided by the demographic characteristics of patients discharged, geographic region of hospitals, conditions diagnosed, and surgical and nonsurgical procedures performed. Measurements of hospital use include frequency, rate and percent of discharges and days of care, and average length of stay.

Entities:  

Mesh:

Year:  1995        PMID: 7545855

Source DB:  PubMed          Journal:  Vital Health Stat 13        ISSN: 0083-2006


  7 in total

Review 1.  Diastolic heart failure in the elderly.

Authors:  Dalane W Kitzman
Journal:  Heart Fail Rev       Date:  2002-01       Impact factor: 4.214

Review 2.  Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction.

Authors:  F A Mitropoulos; J A Elefteriades
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

Review 3.  Endothelin in heart failure.

Authors:  G Sütsch; M Barton
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

Review 4.  Respiratory diseases among U.S. military personnel: countering emerging threats.

Authors:  G C Gray; J D Callahan; A W Hawksworth; C A Fisher; J C Gaydos
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

5.  ELITE II and Val-HeFT are different trials: together what do they tell us?

Authors:  Kenneth Dickstein
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

6.  What do parents want from their child's asthma treatment?

Authors:  Stefan Walzer
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

7.  Willingness-to-pay for caregivers of children with asthma or wheezing conditions.

Authors:  Stefan Walzer; Peter Zweifel
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.